AUSTIN, Texas — In this Healio Video Perspective from the North American Neuro-Ophthalmology Society meeting, Prem Subramanian, MD, PhD, discusses the sustained efficacy of teprotumumab in patients with thyroid eye disease.
Uncategorized
VIDEO: Teprotumumab efficacy sustained after 6 months in thyroid eye disease